e-Drug3D

829

cas 661-19-8

CLASS

DERMATOLOGICALS
ANTIVIRAL
BLOCK THE VIRUS FROM ENTERING THE HEALTHY SKIN CELLS

ROUTE (list)

TOPICAL

PK parameters

MW 326.59
NB_atoms 23
XLogP 7.80
PSA 21.406
NB_HD 1
NB_HA 1
fsp3 1.00
Lipinski(0=no;1=yes) 0

FDA
NDA 020941 (label) INN (DOCOSANOL) ABREVA (HALEON US HOLDINGS) APPROVAL= AP YEAR= 2000 NEWMOLECULARENTITY
NDA 208754 (pdf not found) INN (DOCOSANOL) DOCOSANOL (P AND L) APPROVAL= AP YEAR= 2018
NDA 215839 (pdf not found) INN (DOCOSANOL) DOCOSANOL (ALEMBIC) APPROVAL= AP YEAR= 2022
NDA 212385 (pdf not found) INN (DOCOSANOL) DOCOSANOL (P AND L DEVELOPMENT) APPROVAL= AP YEAR= 2022
NDA 214454 (pdf not found) INN (DOCOSANOL) DOCOSANOL (TARO) APPROVAL= AP YEAR= 2023
NDA 217090 (pdf not found) INN (DOCOSANOL) DOCOSANOL (AUROBINDO PHARMA LTD) APPROVAL= AP YEAR= 2024